Checkpoint Therapeutics Inc (NASDAQ: CKPT): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

CKPT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $2.23 and fluctuated between $2.3300 as its day high and $2.1087 as its day low. The current market capitalization of Checkpoint Therapeutics Inc is $52.47M. A total of 0.61 million shares were traded on the day, compared to an average of 948.72K shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, CKPT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 11 BUYs and 0 SELLs from insiders. Insiders purchased 659,710 shares during that period but sold 0.

In the most recent transaction, Oliviero James F III sold 5,894 shares of CKPT for 2.06 per share on Feb 28. After the transaction, the CEO, President and Director now owns 350,836 company shares. In a previous transaction on Feb 28, GRAY WILLIAM GARRETT sold 2,035 shares at 2.07 per share. CKPT shares that Chief Financial Officer owns now total 145,224.

Among the insiders who sold shares, Oliviero James F III disposed of 11,900 shares on Feb 01 at a per-share price of $2.01. This resulted in the CEO, President and Director holding 369,680 shares of CKPT after the transaction. In another insider transaction, GRAY WILLIAM GARRETT sold 4,115 shares at $1.95 per share on Feb 01. Company shares held by the Chief Financial Officer now total 147,259.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CKPT has a high of $5.58 and a low of $1.30.

As of this writing, CKPT has an earnings estimate of -$0.54 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.4 per share and a lower estimate of -$0.8. The company reported an EPS of -$1.05 in the last quarter, which was -34.60% lower than expectations of -$0.78.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CKPT’s latest balance sheet shows that the firm has $54.73M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was -$0.85, while its Total Shareholder’s Equity was $29.75M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CKPT is Buy with a score of 5.00.

Most Popular

Related Posts